These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6993030)

  • 1. Studies on monocomponent insulin. IV. Subcutaneous absorption of insulin from preparations with protracted action.
    Kasama T; Oshiro K; Uchida M; Okubo T; Kamiyama N; Sugiura M
    Chem Pharm Bull (Tokyo); 1980 Feb; 28(2):379-86. PubMed ID: 6993030
    [No Abstract]   [Full Text] [Related]  

  • 2. Miscibility of human and bovine ultralente insulin with soluble insulin.
    Mühlhauser I; Broermann C; Tsotsalas M; Berger M
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1656-7. PubMed ID: 6439364
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.
    Fischer U; Freyse EJ; Jutzi E; Besch W; Raschke M; Höfer S; Albrecht G
    Diabetologia; 1983 Mar; 24(3):196-201. PubMed ID: 6341148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat.
    Okumura K; Komada F; Hori R
    J Pharmacobiodyn; 1985 Jan; 8(1):25-32. PubMed ID: 3891962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in solubility of insulin in therapeutic mixtures of insulin preparations: HPLC analysis.
    Arakawa Y; Kurokawa N; Maeda Y; Yanaihara C
    Diabetes Res Clin Pract; 1989; 7 Suppl 1():S93-100. PubMed ID: 2680372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change to U-100 insulin does not appear to affect insulin absorption.
    Swift PG; Kennedy JD; Gerlis LS
    Br Med J (Clin Res Ed); 1983 Mar; 286(6370):1015. PubMed ID: 6403173
    [No Abstract]   [Full Text] [Related]  

  • 7. Absorption of injected insulin. A clinical-pharmacological study.
    Binder C
    Acta Pharmacol Toxicol (Copenh); 1969; 27 Suppl 2():1-84. PubMed ID: 4908935
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
    Kemmer FW; Sonnenberg G; Cüppers HJ; Berger M
    Diabetes Care; 1982; 5 Suppl 2():23-8. PubMed ID: 6765535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sauna-induced acceleration in insulin absorption from subcutaneous injection site.
    Koivisto VA
    Br Med J; 1980 Jun; 280(6229):1411-3. PubMed ID: 7000239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects.
    Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD
    Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin pharmacology.
    Skyler JS
    Med Clin North Am; 1988 Nov; 72(6):1337-54. PubMed ID: 3054356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin levels in diabetics after subcutaneous administration of Rapitard insulin.
    Yuen RW; Taylor DR; Welborn TA
    Med J Aust; 1975 Dec 20-27; 2(25-26):934-6. PubMed ID: 1221276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes].
    Home PD
    Journ Annu Diabetol Hotel Dieu; 1995; ():243-55. PubMed ID: 7602885
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.
    Guerra SM; Kitabchi AE
    J Clin Endocrinol Metab; 1976 May; 42(5):869-74. PubMed ID: 1270578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypoglycemic effect of immobilized insulin in experimental diabetes].
    Morenkova SA; Levin FB; Karelin AA; Berezov TT
    Biull Eksp Biol Med; 1984 Jun; 97(6):647-8. PubMed ID: 6378266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.
    Kraegen EW; Chisholm DJ
    Clin Pharmacokinet; 1985; 10(4):303-14. PubMed ID: 3899451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of insulin from self-assembling nanofiber hydrogel, PuraMatrix™: application for the subcutaneous injection in rats.
    Nishimura A; Hayakawa T; Yamamoto Y; Hamori M; Tabata K; Seto K; Shibata N
    Eur J Pharm Sci; 2012 Jan; 45(1-2):1-7. PubMed ID: 22064453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.
    Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P
    Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in method of insulin delivery].
    Anazawa S; Matsuoka K
    Nihon Rinsho; 1990 Dec; 48 Suppl():1022-30. PubMed ID: 2086863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.